immobilized Cibacron Blue has been taken as evidence that the protein contains a dinucleotidebinding domain (Thompson et al., 1975; Wilson, 1976) . However, other proteins such as interferon (Maeyer-Guignard et al., 1977; Jankowski et al., 1976) and human serum albumin (Travis & Pannell, 1973; Travis et al., 1976) , which may not possess a dinucleotide-binding domain, have also been shown to bind to Cibacron Blue.
The interaction of immobilized Cibacron Blue with human serum albumin has been used not only to isolate the latter from plasma, but also to remove albumin before the isolation of other plasma-protein fractions, allowing albumin-free preparations (Travis et al., 1976) . Furthermore, it has been found that this is not a general property of serum albumins as a class, since only human serum albumin is reported to bind to Cibacron Blue-Sepharose, whereas albumins from rabbit, chicken and bovine sera do not bind to the same adsorbent (Iqbal & Johnson, 1977 Because of the widespread interest in the use of immobilized Cibacron Blue in plasma fractionation, the present study was undertaken to examine the different interactions of serum albumins with Cibacron Blue-Sepharose and to attempt to elucidate the mechanismn of binding of human serum albumin to Cibacron Blue.
The known physiological functions of albumin include the binding and transport of long-chainfatty acid anions, and the binding and detoxification of unconjugated bilirubin (Peters, 1975) . The binding of these two ligands occurs primarily at separate sites, with fatty acids not interfering with bilirubin binding until five or more fatty acid molecules are bound per albumin molecule (Wooley & Hunter, 1970) . Human serum albumin can bind 7mol of fatty acid/mol with high affinity and then more with lower affinity (Goodman, 1958) , or 3mol of bilirubin/mol (Jacobson, 1969) . Thus the effect of these molecules on the binding of human serum albumin to Cibacron Blue was studied.
Experimental

Materials
Sepharose was obtained from Pharmacia. Palmitic acid was obtained from BDH. Bilirubin, rabbit serum albumin (crystallized and freeze-dried; lot 27C-3963) and horse serum albumin (fraction V; lot 108C-8 120) were obtained from Sigma; sheep serum albumin (crystallized) was obtained from Miles Laboratories; and bovine serum albumin (fraction V; pure; batch 76638) was obtained from KochLight. Human serum albumin was either purchased R. J. LEATHERBARROW AND P. D. G. DEAN from Sigma (fraction V) or prepared from plasma on Cibacron Blue-Sepharose 6B columns by using the meth-od of Travis et al. (1976) . Cibacron Blue F3G A was obtained from Ciba-Geigy. Other triazine-based compounds were a gift from ICI. Outdated blood-bank plasma was obtained from The Royal Liverpool Hospital Blood Bank.
Methods
(i) Preparation of matrices. Dye-Sepharose derivatives were prepared by using the method of Heyns & De Moor (1974) . Cibacron Blue was also coupled via its free amino group to epoxy-activated Sepharose 6B (Porath, 1974) (Wooley & Hunter, 1970) . A280 measurements on bilirubin/albumin solutions ,were corrected for the contribution to the A280 by bilirubin. This correction factor was found to be 16.5% of the maximum absorbance at 450-470nm. All solutions containing bilirubin were protected from light.
(iv) Column experiments. All the micro columns used were obtained from Bio-Rad Laboratories (6mm diam.) and contained 1.0 ml of settled gel. Albumin (10mg) in 0.45ml of solution containing bilirubin or palmitate as appropriate was applied to a column that had been pre-equilibrated with 0.025 Mbuffer. In the experiments where the pH was varied, the volume of the applied albumin solution was 0.20 ml. Unbound protein was washed through with 10 column-volumes of the same buffer and the unbound albumin was measured. Albumin concentrations were determined on the basis of their A280, with the appropriate albumin solutions as standards in each case. Bound albumin was calculated by difference and checked by determining the amount of albumin that was eluted by thiocyanate.
The use of 0.2 M-NaSCN solution to elute albumin from the columns (Travis et al., 1976 ) was found to cause significant 'tailing' and did not completely remove all bound protein. Therefore unless the albumin was required preparatively, the use of 0.5 M-NaSCN/0.05 M-Tris/HCl, pH 8.0, was found to be more satisfactory. All column experiments were carried out at 50C.
(v) N.m.r. studies. N.m.r. spectra were recorded at 25°C in 0.01 M-phosphate-buffered 2H20 [pH* (apparent pH) 8.0]. Measurements were made by using a Bruker WH 270 machine in Fouriertransform mode over a 4000Hz sweep width. Selective decoupling was applied to diminish the 'H2HO peak. Unless stated, the number of scans used was 10000. The protein solution used contained 1.0 M-human serum albumin (0.5 ml) and had been allowed to exchange in 2H20 overnight.
Human serum albumin was extracted from plasma for n.m.r. studies on Cibacron Blue-Sepharose 6B columns at pH 8.5 by using the method of Travis et al. (1976) . It was then further purified using a second, smaller, Cibacron Blue-Sepharose column by applying a saturating amount of albumin solution in order to eliminate binding of any other protein contaminants by competition. Any remaining contaminants were removed with 0.2 M-KCI/0.025M-Tris/HCI (pH 8.5) (losses of human serum albumin are minimal under these conditions). Human serum albumin desorption was effected by using 0.2 M-NaSCN/0.05 M-Tris/HCI, pH 8.0.
The eluate was rapidly dialysed by using a hollowfibre cartridge (Amicon HlOP10 (Ornstein, 1964 ) the purified human serum albumin was found to migrate as a single band.
Results
Preliminary experiments indicated that Cibacron Blue-Sepharose would remove essentially all the albumin from human plasma but not from sheep or bovine sera. The results of applying human and sheep sera to Cibacron Blue-Sepharose 4B columns (1.Oml) at pH8.6 are shown in Fig. 1 (Angal & Dean, 1978) . Therefore the binding of different albumins to Cibacron Blue-Sepharose 4B columns at various pH values was studied. The effect of pH on binding is shown in Fig. 2 Fig. 3 Fig. 4 . As for the albumin/ palmitate experiments, there is a marked difference between the behaviour of human serum albumin and the other albumins. However, in this case the binding of human serum albumin diminishes with increasing concentration of bilirubin, whereas the other albumins show only minor decreases in binding.
Binding ofalbumins to other triazine dyes
A number of compounds structurally similar to Cibacron Blue are available (see Fig. 5 ). These dyes were immobilized on Sepharose at similar ligand concentrations. Cibacron Blue was also immobilized via its free amino group as described under 'Methods'. The relative binding of albumins to these matrices at pH 8.6 was studied. The results of these experiments are shown in Table 1 . None of the matrices bound human serum albumin to the same extent as did Cibacron Blue, even though the structure of the ligands is similar. The aminocoupled Cibacron Blue showed very low binding to all albumins. Differences in ligand concentration account for changes in column capacity between experiments; however, these changes do not account for changes in the order of binding between different albumins, since the ligand concentration for any one experiment was the same. IH n.m.r. ligand-binding studies on human serum albumin/Cibacron Blue and human serum albumin/bilirubin IH n.m.r. spectra of human serum albumin (1.0mM), human serum albumin (1.0mM) in the presence of 0.5, 1.0, 2.0 and 3.0mM-Cibacron Blue, and human serum albumin (1.0 mM) with 2 mMbilirubin, were recorded and difference spectra of human serum albumin/Cibacron Blue minus human serum albumin and human serum albumin/bilirubin minus human serum albumin were plotted (see Figs. 6 and 7 ). These were compared with each other and with spectra of Cibacron Blue and bilirubin. Spectra of Cibacron Blue showed quite large changes with concentration, presumably due to intermolecular stacking.
Over the Cibacron Blue/human serum albumin range 0.5-2.0 the peak heights in the difference spectra are proportional to the concentration of Cibacron Blue, with the peaks occurring in identical positions. 
Discussion
Our results showed that removal of albumin by use of a Cibacron Blue-Sepharose column is more effective with human plasma than with any of the other columns used. This partly confirms the findings of Iqbal & Johnson (1977) that human serum albumin would bind to Cibacron BlueSepharose, whereas serum albumins from several other sources would not. The fact that we found some binding of the other albumins is probably due to the Cibacron Blue-Sepharose in our experiments being of higher ligand concentration. We estimate from their results of capacities for human serum albumin that our Cibacron Blue-Sepharose had a 2-3-fold greater ligand concentration. Ligand concentration was found to be very important in the relative binding of the different albumins, with higher ligand concentrations greatly facilitating binding of the weaker-binding albumins. The overall trends found in our experiments were, however, the same irrespective of ligand concentration.
The presence of two bands moving more slowly than albumin on the gels from the SCN-eluates (Fig. 1) deserves some comment. It has been shown (Travis & Pannell, 1973; Travis et al., 1976 ) that, as well as human serum albumin, Cibacron Blue columns also bind lipoprotein, which is not removed by 0.2M-NaSCN, pH 8.0. In our experiment, 0.5M-NaSCN, pH 8.0, was used, which seems also to remove this lipoprotein. This result shows that other plasma proteins bind to Cibacron Blue-Sepharose and that elution with 0.2 M-NaSCN, pH 8.0, makes the procedure selective for albumin.
The pH of adsorption is shown to affect the (Angal & Dean, 1978 (Travis & Pannell, 1973; Seelig & Colman, 1977; MaeyerGuignard et al., 1977; Jankowski et al., 1976) . The binding of human serum albumin is largely unaffected by palmitate; however, it does decrease to some extent when the palmitate/albumin ratio is greater than 3:1. This behaviour is similar to bilirubin binding in the presence of fatty acid (Wooley & Hunter, 1970 None of the other triazine dyes bound human serum albumin to the same extent as did Cibacron Blue. This indicates that the structural requirements for the affinity ligand are reasonably stringent, as the whole of the Cibacron Blue structure seems to be required. Comparison of these results with those obtained from the binding of such triazine dyes to nucleotide-dependent proteins (Beissner & Rudolph, 1978) suggests that these structural requirements are more rigid for human serum albumin than for those proteins that bind nucleotides, at least in so far as the differences demonstrated by the ligands used in the present study. Procion Blue MX3G and MXR both showed lower capacities for albumins than the other dyes. This could be due to the MX3G and MXR dyes being less negatively charged than Cibacron Brilliant Blue or Cibacron Blue and so bind less well to albumins, which are known to bind anions.
The amino-coupled Cibacron Blue showed very low binding to all albumins. The decreased binding of human serum albumin by this ligand suggests that, when Cibacron Blue binds, the anthraquinone ring system is buried in the protein and so attachment of a spacer arm to this portion restricts binding. Alternatively the amino group itself could be important in binding. This decreased binding of human serum albumin to amino-coupled Cibacron Blue has also been noted with CNBr-activated Sepharose (Travis et al., 1976; Pannell et al., 1974) .
In order to assess whether Cibacron Blue and bilirubin bind to the same site(s) of human serum albumin, ligand-binding studies were performed by using n.m.r. If these ligands bind to the same site(s), then it would be expected that the difference spectra Vol. 189 33 34 R. J. LEATHERBARROW AND P. D. G. DEAN from human serum albumin/Cibacron Blue minus human serum albumin, and human serum albumin/ bilirubin minus human serum albumin would be identical (except for resonances from Cibacron Blue or bilirubin themselves), as the same proton resonances in the protein would be affected in each case. A comparison of the difference spectra reveals that, although they appear to be complicated, the positions of the peaks are the same in each case, except for peaks attributable to Cibacron Blue or bilirubin. Therefore in general we consider that there are enough similarities in the way that Cibacron Blue and bilirubin affect the human serum albumin proton resonances to conclude that they bind to the same or similar sites.
The large peak in the difference spectra at c = 2.9 p.p.m. is likely to be associated with alterations in the chemical shift of lysine e-CH2 proton resonances. Thus it is reasonable to suppose that these positively charged residues bind to the negatively charged Cibacron Blue or bilirubin molecules. This could offer an explanation for the decrease in binding of human serum albumin to Cibacron Blue-Sepharose at around pH9 (Fig. 2) , as at this pH the lysine residues could be becoming deprotonated.
In conclusion, there appear to be two types of interaction of Cibacron Blue with albumins. The first is demonstrated by all albumins and is with the hydrophobic fatty acid-anion-binding sites. The second, stronger interaction, which is demonstrated only by human serum albumin of those proteins presently studied, is to the bilirubin-binding site(s). Since this latter interaction is the stronger, and since it is not dependent on the fatty acid content of the albumin (which would vary depending on the diet of the animal in question), human serum albumin was found to be easier to separate from plasma than any of the other albumins when Cibacron Blue columns were used.
